Package | us.nlm.vsac |
Type | ValueSet |
Id | Id |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.1444.5.229/expansion |
Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.229 |
Version | 20210522 |
Status | active |
Date | 2021-05-22T01:00:44-04:00 |
Name | MinimalEmeticRiskIntravenousAntineoplasticAgent |
Title | Minimal Emetic Risk Intravenous Antineoplastic Agent |
Experimental | False |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: The purpose of this value set is to represent concepts of medications for minimal emetic risk intravenous antineoplastic.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication for minimal emetic risk intravenous antineoplastic.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.) |
No resources found
{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113883.3.1444.5.229",
"meta" : {
"versionId" : "7",
"lastUpdated" : "2023-12-21T17:43:03.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "American Society of Clinical Oncology Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-10-09"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2021-05-22"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.229",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.3.1444.5.229"
}
],
"version" : "20210522",
"name" : "MinimalEmeticRiskIntravenousAntineoplasticAgent",
"title" : "Minimal Emetic Risk Intravenous Antineoplastic Agent",
"status" : "active",
"experimental" : false,
"date" : "2021-05-22T01:00:44-04:00",
"publisher" : "American Society of Clinical Oncology Steward",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts of medications for minimal emetic risk intravenous antineoplastic.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication for minimal emetic risk intravenous antineoplastic.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)",
"compose" : {
"include" : [
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.178"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.179"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.180"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.181"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.182"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.183"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.184"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.185"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.186"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.187"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.188"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.189"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.190"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.191"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.192"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.194"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.179"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.599"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.600"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.202"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.1"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.158"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.153"
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:1abcf4f1-ce9b-459e-98e2-c37260b47994",
"timestamp" : "2024-12-10T10:13:33-05:00",
"total" : 75,
"contains" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1304995",
"display" : "31 ML vincristine sulfate liposome 0.16 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1442693",
"display" : "40 ML obinutuzumab 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1657005",
"display" : "40 ML ipilimumab 5 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1657012",
"display" : "10 ML ipilimumab 5 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1657066",
"display" : "4 ML bevacizumab 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1657073",
"display" : "16 ML bevacizumab 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1657190",
"display" : "4 ML nivolumab 10 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1657195",
"display" : "10 ML nivolumab 10 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1657746",
"display" : "pembrolizumab 50 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1657750",
"display" : "4 ML pembrolizumab 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1657775",
"display" : "10 ML ramucirumab 10 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1657780",
"display" : "50 ML ramucirumab 10 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1657862",
"display" : "10 ML rituximab 10 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1657867",
"display" : "50 ML rituximab 10 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1658042",
"display" : "50 ML ofatumumab 20 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1658047",
"display" : "5 ML ofatumumab 20 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1721951",
"display" : "5 ML daratumumab 20 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1726439",
"display" : "20 ML daratumumab 20 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1726673",
"display" : "bleomycin 15 UNT Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1726676",
"display" : "bleomycin 30 UNT Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1729418",
"display" : "1 ML vinorelbine 10 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1729422",
"display" : "5 ML vinorelbine 10 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1740864",
"display" : "fludarabine phosphate 50 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1740865",
"display" : "2 ML fludarabine phosphate 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1792780",
"display" : "20 ML atezolizumab 60 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1796419",
"display" : "1 ML pralatrexate 20 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1796424",
"display" : "2 ML pralatrexate 20 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1863343",
"display" : "1 ML vincristine sulfate 1 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1863354",
"display" : "2 ML vincristine sulfate 1 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1875542",
"display" : "10 ML avelumab 20 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1919507",
"display" : "2.4 ML durvalumab 50 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1919515",
"display" : "10 ML durvalumab 50 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1922509",
"display" : "trastuzumab 150 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1922516",
"display" : "trastuzumab 21 MG/ML Injectable Solution"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1991412",
"display" : "24 ML nivolumab 10 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2046140",
"display" : "16 ML bevacizumab-awwb 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2046148",
"display" : "4 ML bevacizumab-awwb 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2058830",
"display" : "7 ML cemiplimab-rwlc 50 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2104611",
"display" : "2 ML emapalumab-lzsg 5 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2104621",
"display" : "10 ML emapalumab-lzsg 5 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2105826",
"display" : "10 ML rituximab-abbs 10 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2105834",
"display" : "50 ML rituximab-abbs 10 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2107053",
"display" : "trastuzumab-pkrb 21 MG/ML Injectable Solution"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2119695",
"display" : "14 ML atezolizumab 60 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2119714",
"display" : "5 ML hyaluronidase-oysk 2000 UNT/ML / trastuzumab-oysk 120 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2169359",
"display" : "trastuzumab-pkrb 150 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2174095",
"display" : "polatuzumab vedotin-piiq 140 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2174804",
"display" : "trastuzumab-anns 21 MG/ML Injectable Solution"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2179753",
"display" : "trastuzumab-dkst 150 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2179760",
"display" : "trastuzumab-dkst 21 MG/ML Injectable Solution"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2257297",
"display" : "trastuzumab-anns 150 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2268039",
"display" : "4 ML bevacizumab-bvzr 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2268047",
"display" : "16 ML bevacizumab-bvzr 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2273512",
"display" : "10 ML rituximab-pvvr 10 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2273520",
"display" : "50 ML rituximab-pvvr 10 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2280732",
"display" : "trastuzumab-qyyp 21 MG/ML Injectable Solution"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2289227",
"display" : "trastuzumab-dttb 150 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2289234",
"display" : "trastuzumab-dttb 21 MG/ML Injectable Solution"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2380771",
"display" : "20 ML emapalumab-lzsg 5 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2390949",
"display" : "0.4 ML ofatumumab 50 MG/ML Pen Injector"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "239178",
"display" : "vinblastine sulfate 1 MG/ML Injectable Solution"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2398131",
"display" : "polatuzumab vedotin-piiq 30 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "240754",
"display" : "10 ML cladribine 1 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2472327",
"display" : "10 ML rituximab-arrx 10 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2472335",
"display" : "50 ML rituximab-arrx 10 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2472791",
"display" : "trastuzumab-qyyp 150 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2569080",
"display" : "12 ML nivolumab 10 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2599043",
"display" : "4 ML bevacizumab-maly 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2599051",
"display" : "16 ML bevacizumab-maly 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2627650",
"display" : "4 ML bevacizumab-adcd 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2627658",
"display" : "16 ML bevacizumab-adcd 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2665325",
"display" : "20 ML emapalumab-lzsg 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2665330",
"display" : "2 ML emapalumab-lzsg 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2665332",
"display" : "10 ML emapalumab-lzsg 25 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2665334",
"display" : "4 ML emapalumab-lzsg 25 MG/ML Injection"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.